Thrombosis of legs arteries: Imputability of anti-phosphatidylethanolamine antibodies?;Thromboses artérielles des membres inférieurs: Responsabilité des anticorps antiphosphatidyléthanolamine?

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 6-7 I, 2005, Pages 555-558

  Blaise, S ^a   Seinturier, C ^a   Imbert, B ^a   Beani, J C ^a   Carpentier, P H ^a  

^a HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CHOLESTEROL; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLETHANOLAMINE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BELOW KNEE AMPUTATION; CASE REPORT; DISEASE CLASSIFICATION; EMBOLISM; FEMORAL ARTERY; GANGRENE; HUMAN; LEG ARTERY; LEG ARTERY THROMBOSIS; MALE; NEOPLASM; SKIN NECROSIS; STENT; THROMBOPHILIA; VASCULITIS;

EID: 22344432644     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79338-8     Document Type: Article

References (13)

1. Wilson WA, Gharavi AE, Koike T, Locksin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
2. Petit A. Le syndrome des antiphospholipides. Ann Dermatol Venereol 2001;128:7-9.
3. Bidot CJ, Jy W, Horstmann LL, Huisheng H, Jimenez JJ, Yaniz M, et al. Factor VII/VIIa: a new antigen in the antiphospholipid antibody syndrome. Br J Haematol 2003;120:618-26.
4. Karmochkine M, Cacoub P, Piette JC, Godeau P, Boffa MC. Anti-phosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis. Clin Exp Rheum 1992; 10:603-5.
5. Bérard M, Chantome R, Marcelli A, Boffa MC. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. Association with thrombosis and vascular cutaneous diseases. J Rheumatol 1996; 23:1369-74.
6. Desauw C, Hachulla E, Boumbar Y, Bouroz-Joly J, Ponard D, Arvieux J, et al. Syndrome des antiphospholipides avec anticorps antiphosphatidylé thanolamine isolés: à propos de 20 cas. Rev Med Interne 2002;23:357-63.
7. Sanmarco M, Alessi MC, Harle JR, Sapin C, Aillaud MF, Gentile S, et al. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb Haemost 2001;85:800-5.
8. Sugi T, Katsunuma J, Izumi SI, McIntyre J, Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertility and Sterility 1999;71:1060-5.
9. Sugi T, McIntyre JA. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens. J Autoimmun 2001;17:207-14.
10. McIntyre JA, Wagenknecht DR. Anti-phosphatidylethanolamine (aPE) Antibodies: a survey. J Autoimmun 2000;15:185-93.
11. Granel B, Serratrice J, Hubert AM, Volot F, Pache X, Swiader L, et al. Hyper-immunoglobulinémie M et anticorps antiphosphatidylé thanolamine d'isotype IGM: étude clinicobiologique de 72 patients porteurs d'immunopathie. Rev Med Interne 2000;21:595-8.
12. Wilson WA, Gharavi AE, Piette JC. International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium. Lupus 2001;10: 457-60.
13. th International Congress on antiphospholipid antibodies - summary. Autoimmunity Reviews 2003;2:79-85.